Chromosome imbalances and alterations in the p53 gene in uterine myomas from the same family members: Familial leiomyomatosis in Turkey

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 651-658

  Hakverdi, Sibel ^a   Demirhan, Osman ^b   Tunc, Erdal ^b   Inandiklioglu, Nihal ^b   Uslu, Inayet Nur ^b   Gungoren, Arif ^a   Erdem, Duygu ^a   Hakverdi, Ali Ulvi ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Chromosomal aberrations; Familial leiomyomatosis; FISH; P53 gene; Turkey; Uterine myomas

Indexed keywords

PROTEIN P53;

ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; FAMILY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; LEIOMYOMATOSIS; TURKEY (REPUBLIC); UTERUS CANCER;

CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CYTOGENETIC ANALYSIS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEIOMYOMATOSIS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TURKEY; UTERINE NEOPLASMS;

EID: 84877677565     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.651     Document Type: Article

References (51)

1. Amada S, Nakuno H, Tsuneyoski M (1995). Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA, flow cytometry, and muscle specific actins. Int J Gynecol Pathol, 14, 134-42.
2. Blom R, Guerrieri C, Stal O, et al (1998). Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 49 cases. Gynecol Oncol, 68, 54-61.
3. Brosens I, Deprest J, Dal CP, et al (1998). Clinical significance of cytogenetic abnormalities in uterine myomas. Fertil Steril, 69, 232-5.
4. Bullerdiek J, Bartnitzke S, Weinberg M, et al (1987). Rearrangements of chromosome region 12q13-15 in pleomorphic adenomas of the human salivary gland (PSA). Cytogenet Cell Genet, 45, 187-190.
5. Chen PL, Chen YM, Bookstein R, et al (1990). Genetic mechanisms of tumor suppression by human p53 gene. Science, 250, 1576-80.
6. Corbin S, Neilly ME, Espinosa R, et al (2002). Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res, 62, 3477-84.
7. Cramer SF, Patel A, (1990). The frequency of uterine leiomyomas. Am J Clin Path, 94, 435-8.
8. Dal Cin P, Vanni R, Marras S, et al (1995). Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res, 55, 1565-8.
9. De Vos S, Wilczynski SP, Fleischhacker, et al (1994). p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol Oncol, 54, 205-8.
10. Dubourg C, Toutain B, Helias C, et al (2002). Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene. Cancer Genet Cytogenet, 134, 33-37.
11. Dumanski JP (1996). The human chromosome 22-located genes and malignancies of the central nervous system. Neuropathol Appl Neurobiol, 22, 412-7.
12. Fearon ER, Cho KR, Nigro JM, et al (1990). Identification of a chromosome 18q gene that is altered in colorectal cancers. Science, 247, 49-56.
13. Flüry-Herard A, Viegas-Pequignot E, De Cremoux H, et al (1992). Cytogenetic study of five cases of lung adenosquamous carcinomas. Cancer Genet Cytogenet, 59, 1-8.
14. Galteland E, Sivertsen EA, Svendsrud DH, et al (2005). Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas. Leukemia, 19, 2313-23.
15. Hahn SA, Schutte M, Hoque AT, et al (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271, 350-3.
16. Hall KL, Tencriello MG, Taylor RR, et al (1997). Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol, 65, 330-35.
17. Havel G, Wedell B, Dahlenfors R, Mark J et al (1989). Cytogenetic relationship between uterine lipoleiomyomas and typical leiomyomas. Virchows Arch B Cell Pathol Incl Mol Pathol, 57, 77-79.
18. Hayashi V, Kanda N, Inaba T, et al (1989). Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer, 63, 126-132.
19. Hibi K, Takahashi T, Yamakawa K, et al (1992). Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7, 445-9.
20. Heim S, Mandahi N, Kristoffersson U, et al (1987). Marker ring chro¬mosorne-a new eylogenetie abnormality characterizing lipo¬genic tumors. Cancer Genet Cytogenet, 24, 319-26.
21. Heim S, Nilbert M, Vanni R, et al (1988). A specific translocation t(12;14)(q13-15;q23-q24), characterizes a subgroup of uterine leiomyomas. group. This study confirms previous reports of a correlation. Cancer Genet Cytogenet, 32, 13-17.
22. Hennig Y, Wanschura S, Deichert U, et al (1996). Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps. Mol Hum Reprod, 2, 277-83.
23. Hennig Y, Deichert U, Bonk U, et al (1999). Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol Hum Reprod, 5, 1150-54.
24. Hu J, Surti U (1991). Subgroups of uterine leiomyomas based on cytogenetic analysis. Hum Pathol, 22, 1009-16.
25. Huang Q, Yu GP, McCormick SA, et al (2002). Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer, 34, 224-33.
26. Ishwad CS, Ferrell RE, Davare J, et al (1995). Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Genes Chromosomes Cancer, 14, 51-5.
27. Jeffers MD, Farquhaarson MA, Richmond JA, et al (1995). p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumors of the uterine corpus. J Pathol, 177, 65-70.
28. Jung MS, Yun J, Chae HD, et al (2001). p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene, 20, 5818-25.
29. Kiechle-Schwartz M, Sreekantaiah C, Berger CS, et al (1991). Nonrandom cytogenetic changes in leiomyomas of the female genitourinary tract. Cancer Genet Cytogenet, 53, 125-36.
30. Kiechle-Schwartz M, Berger CS, Surti U, et al (1991). Rear¬rangemeni of band 10q22 in lelomyorna and leiomyosarcoma of Ihe uterus. Cancer Genet Cytogenet, 53, 125-36.
31. Kurbanova M, Koroleva AG, Sergeev AS, (1989). Geneticepidemiological analysis of uterine myoma: estimate of risk to relatives. Genetika, 25, 1896-8.
32. Le Beau MM, Espinosa R, Neuman WL, et al (1993). Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci USA, 90, 5484-88.
33. Lefter LP, Furukawa T, Sunamura M, et al (2002). Genes Chromosomes Cancer, 34, 234-242.
34. Li SF, Shiozawa T, Nakayama X, et al (1996). Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer, 17, 321-9.
35. Luoto R, Kaprio J, Rutanen E, et al (2000). Heritability and risk factors of uterine fibroids the Finnish twin cohort study. Maturitas, 37, 15-26.
36. Malkin D, Li FP, Strong LC, et al (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-38.
37. Mandahl N, Orndal C, Heim S, et al (1993). Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas. Cancer, 71, 3009-13.
38. Mark J, Havel G, Grepp C, et al (1990). Chromosomal patterns in human benign uterine leiomyomas. Cancer Genet Cytogenet, 44, 1-13.
39. McAlpine PJ, Shows TB, Boucheli C, et al (1991). The 1991 catalog of mapped genes and report of the nomenclature committee, Human Gene Mapping 11. Cytogenet Cell Genet, 58, 5-102.
40. Milelman F, (1988). Calalog of chromosome aberrations in cancer. 3rd ed. New York: Alan R Liss.
41. Nanashima A, Tagawa Y, Yasutake T, et al (1997). Aneusomy of chromosome 18 is associated with the development of colorectal carcinoma. J Gastroenterol, 32, 487-91.
42. Nilbert M, Heim S, (1990).Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer, 2, 3-13.
43. Nilbert M, Heim S, Mandahi N, et al (1990). Characteristic chromosome abnormalities, ineluding rearrangements of 6p,del(7q),+12 and t(12;14), in 44 uterine leiomyomas. Hum Genet, 85, 605-11.
44. Nilbert M, Heim S, Mandahl N, et al (1989). Different karyotypic abnormalities, t(1;6) and del(7), in two uterine leiomyomas from the same patient. Cancer Genet Cytogenet, 42, 51-3.
45. Niemann TH, Raab SS, Lenel JC, et al (1995). p53 protein overexpression in smooth muscle tumors of the uterus. Hum Pathol, 26, 375-9.
46. Oren M (1992). p53: the ultimate tumor suppressor gene? FASEB J, 6, 3169-76.
47. Ozisik YY, Meloni AM, Altungoz O, et al (1995). Translocation (6;10) (p21;q22) in uterine leiomyomas. Cancer Genet Cytogenet, 79, 136-8.
48. Ozisik YY, Meloni AM, Surti U, et al (1993). Deletion 7q22 in uterine leiomyomata. A cytogenetic review. Cancer Genet Cytogenet, 23, 305-13.
49. Ozisik YY, Meloni AM, Powell M, et al (1993). Chromosome 7 biclonality in uterine leiomyoma. Cancer Genet Cytogenet, 67, 59-64.
50. Quade BJ, Cin PD, Neskey DM, et al (2002). Intravenous Leiomyomatosis: Molecular and Cytogenetic Analysis of a Case. Mod Pathol, 15, 351-56.
51. Pandis N, Jin Y, Gorunova L, et al (1995). Chromosome analysis of 97 primary carcinomas of the breast: Identification of eight karyotypic subgroups. Genes Chrom Cancer, 12, 173-185.